Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023

Revenue of $67.2 million for the year and $18.4 million for the 4th quarter; Adj. EBITDA of $11.5 million for the year and $3.7 million for the quarterBEVERLY, Mass. and TORONTO, March 27, 2024 --...

Related Keywords

Canada ,Toronto ,Ontario ,China ,United States ,Canadian ,America ,Francesco Fragasso ,Kate Torchilin ,Glen Akselrod ,See The Company Management Discussion ,International Financial Reporting Standards ,Hamilton Thorne ,Company Management Discussion ,Hamilton Thorne Ltd ,Assisted Reproductive Technologies ,Chief Executive Officer ,Twelve Month Periods Ending December ,Financial Position ,Fourth Quarter ,Management Discussion ,Chief Financial Officer ,North America ,Thorne Call ,Embryotech Laboratories ,Organic Growth ,Constant Currency ,Markets ,